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high risk patients.
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PS120.
Are Outcomes of Tibial Artery Atherectomy or Stent-
ing Superior to Tibial Angioplasty Alone Over Time in
the US Medicare Population?
Todd R. Vogel1, Viktor Y. Dombrovskiy1, Paul B. Haser1,
Jeffrey L. Carson2, Alan M. Graham1. 1Department of
Surgery, UMDNJ-Robert Wood Johnson Medical School,
New Brunswick, NJ; 2Department of Medicine, UMDNJ-
Robert Wood Johnson Medical School, New Brunswick, NJ
Objectives: Catheter-based revascularization for the
tibioperoneal vessels is increasingly performed for limb
salvage. Few data are available evaluating longitudinal
outcomes after tibioperoneal angioplasty alone com-
pared to adjunctive tibial procedures including stenting
and atherectomy.
Methods: Patients undergoing percutaneous tibioper-
oneal interventions with a diagnosis of ulceration were iden-
tified using The Centers for Medicare & Medicaid Services
inpatient claims (2005-2007). Patients were grouped: tib-
ioperoneal angioplasty only (TA); tibioperoneal angioplasty
plus stent placement (TAS); and tibioperoneal angioplasty
plus atherectomy (TAA). Complications and longitudinal
amputation rates were evaluated.
Results: 2,080 patients, with a mean age of
77.98.3 years (57.7% male; 79.1% White, 13.3% Black)
underwent tibioperoneal angioplasty for the indication
of ulceration. Procedures included: TA (56.3%), TAS
(16.2%); TAA (27.5%). Overall initial hospital compli-
cations were not significantly different among groups.
Rates of amputation are presented (See Table). Adjusted
for age, gender, race, procedure, and comorbidities, pre-
dictors of 30- and 90-day, and 1-year amputation were
male gender and diabetes. Mean total hospital charges
were: TA ($50,300), TAS ($65,680; P0.0001); TAA
($54,808; P0.057).
Conclusions: Patients undergoing tibioperoneal an-
gioplasty with concomitant stenting or atherectomy during
their initial intervention for ulceration incurred greater
hospital charges and demonstrated no improvement on
amputation rates over time compared to tibial angioplasty
alone. Future trials of adjunctive tibioperoneal intervention Ore essential to temper cost as they fail to improve long term
imb salvage.
ates of Any Amputation Over Time
rocedure
30-day
Amputation
Rate
90-day
Amputation
Rate
1 Year
Amputation
Rate
ibial Angioplasty
(TA) Alone
10.85% 18.79% 28.27%
A  Stent 9.52% 15.18% 24.70%
A  Atherectomy 9.08% 18.15% 28.10%
-Values
NSNon-
Significant
All Differences
NS
All Differences
NS
All Differences
NS
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S122.
rosthetic Conduit is Equivalent to Alternative Vein
ources for Below-Knee Popliteal Bypass Targets in the
bsence of Single Segment Greater Saphenous Vein
ames T. McPhee, Neal R. Barshes, Louis L. Nguyen,
harles K. Ozaki, Michael Belkin. Vascular & Endovascu-
ar Surgery, Brigham & Women’s Hospital, Boston, MA
Objectives: Single segment greater saphenous vein
SSGSV) is the conduit of choice for femoral to below-knee
opliteal bypass (F-BKP). The purpose of this study was to
etermine the optimal conduit in patients with inadequate
SGSV.
Methods: This is a retrospective review of a prospec-
ively maintained vascular registry. Patients underwent F-
KP bypass with either alternative vein (AV) [arm vein/
pliced GSV/composite vein] or prosthetic conduit (PC)
or any indication.
Results: From 01/95-06/10, 85 patients had unus-
ble SSGSV for F-BKP reconstruction. 33 patients had AV
onduit (18.2% arm vein; 81.8% composite)and 52 patients
ad PC (80.8% PTFE, 13.5% Dacron, 1.9% composite and
.8% cryovein). The AV and PC groups had similar mean
ge (68 vs. 72.1, p.08),DM (57.6% vs. 57.7%,
.6),smoking (15.2% vs. 30.8%, p.08), CAD (57.6% vs.
7.3%, p.2), and CLI (93.9% vs. 86.5%, p.2). Most
ere primary bypass attempts for both AV and PC (90.9%
s. 84.6% p0.3). The CFA was the primary inflow for
oth (87.9% vs. 90.4%, p.5). AV and PC groups had
imilar 30 day mortality (3.0% vs. 1.9%, p.6) and major
orbidity (6.1% vs. 7.7%, p.6). PC patients were more
ikely to be placed on Coumadin (p.001). By five-year life
able analysis, there was no significant difference in terms of
rimary, assisted primary, secondary patency or limb sal-
age rates at mean follow up of 1087 and 665 days (Table).
f the 9 failed AV grafts, 7 had new bypass grafts created,
